Home > Press > ISE-CCM Nanotechnology Index is down -6.29% Year to Date
The ISE-CCM Nanotechnology Index (ISE: TNY) is down -6.29% year to date, versus 3.63% for the S&P 500, 7.29% for the DJIA, and 5.90% for the Nasdaq.
ISE-CCM Nanotechnology Index is down -6.29% Year to Date
New York, NY | Posted on September 12th, 2007
TNY was co-developed by Cronus Capital Markets and the International Securities Exchange (ISE) in New York. TNY comprises 17 of the leading Nanotechnology companies such as; Cabot Corp. (NYSE: CBT), Headwaters Inc. (NYSE: HW), Symyx Technologies Inc. (NASDAQ: SMMX), and FEI COMPANY (NASDAQ: FEIC). TNY is currently trading options in the ISE.
Cronus Capital Markets CEO Michael Soni remarked that "monthly index reports are an important feature of CCM's Index Support Program, especially for an index like TNY which covers an important aspect of the capital markets and receives significant investor interest."
CCM Index Reports, available at no cost to investors and the media, include index descriptions, objectives, volatility analysis, performance returns, product specifications, component breakdowns and component profiles with news links. The TNY report is available on www.iseoptions.com
About Cronus Capital Markets
Cronus Capital MarketsŪ (CCM) is a global investment information firm who strategically produces and introduces, through various forms of analytics and worldwide distribution, information on equity market opportunities. Our equity indexes receive international attention and represent important new benchmarks of growth.
For more information, please click here
Copyright © Cronus Capital MarketsŪ
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
'Exotic' material is like a switch when super thin April 18th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014